Literature DB >> 31162255

Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid.

Duygu Has Simsek1, Serkan Kuyumcu1, Fulya Yaman Agaoglu2, Seher Nilgun Unal1.   

Abstract

In vivo prostate-specific membrane antigen (PSMA) overexpression creates an opportunity for PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid. Herein, we illustrate a patient with metastatic PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid who had intense PSMA uptake on metastatic lesions, followed by radionuclide therapy with Lu-PSMA.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31162255     DOI： 10.1097/RLU.0000000000002645

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  7 in total

1.  PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers.

Authors:  Shuxian An; Gang Huang; Jianjun Liu; Weijun Wei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-10       Impact factor: 10.057

2.  Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck.

Authors:  Thomas J W Klein Nulent; Matthijs H Valstar; Laura A Smit; Ludwig E Smeele; Nicolaas P A Zuithoff; Bart de Keizer; Remco de Bree; Robert J J van Es; Stefan M Willems
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

3.  First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer.

Authors:  Thomas J W Klein Nulent; Robert J J van Es; Stefan M Willems; Arthur J A T Braat; Lot A Devriese; Remco de Bree; Bart de Keizer
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

4.  A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma.

Authors:  Guochang Wang; Mengjiao Zhou; Jie Zang; Yuanyuan Jiang; Xiaohong Chen; Zhaohui Zhu; Xiaoyuan Chen
Journal:  EJNMMI Res       Date:  2022-08-19       Impact factor: 3.434

Review 5.  PSMA PET Imaging and Therapy in Adenoid Cystic Carcinoma and Other Salivary Gland Cancers: A Systematic Review.

Authors:  Boon Fei Tan; Wei Chang Colin Tan; Fu Qiang Wang; Matt Lechner; Volker Hans Schartinger; Daniel Shao Weng Tan; Kelvin Siu Hoong Loke; Wen Long Nei
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

Review 6.  Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.

Authors:  Larissa Di Villeneuve; Ive Lima Souza; Fernanda Davila Sampaio Tolentino; Renata Ferrarotto; Gustavo Schvartsman
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

Review 7.  PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports.

Authors:  M J M Uijen; Y H W Derks; W A M van Gemert; J Nagarajah; R I J Merkx; M G M Schilham; J Roosen; B M Privé; S A M van Lith; C M L van Herpen; M Gotthardt; S Heskamp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-12       Impact factor: 9.236
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.